Mommox (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mommox, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal and perennial forms, as well as nasal polyps in adults and children by reducing inflammation of the nasal mucosa and providing rapid symptom relief with once‑daily dosing.

GNH USA supplies Mommox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mommox, a nasal corticosteroid, is indicated for several inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching, and sneezing. Seasonal allergic rhinitis: provides symptom control during pollen exposure. Perennial allergic rhinitis: manages year‑round nasal inflammation. Nasal polyps: helps shrink polyps and improve nasal airflow.

Mommox may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Epistaxis: occasional nosebleeds. - Headache: transient headache. - Throat irritation: dryness or soreness.

Serious or Rare Side Effects: - Nasal septal perforation: rare tissue damage. - Vision changes: blurred vision or cataract formation. - Systemic corticosteroid effects: adrenal suppression with prolonged high‑dose use.

Before using Mommox, consider the following precautions and warnings. - Pregnancy: safety not established; use only if benefit outweighs risk. - Breastfeeding: unknown; consider potential risk to infant. - Children: dosage may need adjustment; follow prescriber guidance. - Nasal surgery: postpone surgery for at least one week after stopping the spray. - Overuse: prolonged use may increase risk of systemic corticosteroid effects. - Store at room temperature: keep in original container, protect from moisture and heat.

Mommox can interact with other medicines that influence corticosteroid activity or nasal mucosa.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antifungal azoles: monitor for increased local irritation. - Nasal decongestant sprays: may exacerbate nasal irritation. - Antihistamines: generally safe but monitor overall symptom control.